Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome

OBJECTIVE: To describe the clinico-radiologic outcome of MS patients with natalizumab-related progressive multifocal leukoencephalopathy (Nz-PML) surviving and receiving disease-modifying therapy (DMT). METHODS: We describe clinical and radiologic evolution of Nz-PML survivors in an observational re...

Descripción completa

Detalles Bibliográficos
Autores principales: Maillart, Elisabeth, Vidal, Jean-Sebastien, Brassat, David, Stankoff, Bruno, Fromont, Agnès, de Sèze, Jérôme, Taithe, Frédéric, Clavelou, Pierre, Bourre, Bertrand, Delvaux, Valérie, Rico, Audrey, Labauge, Pierre, Tourbah, Ayman, Lebrun, Christine, Pelletier, Jean, Moreau, Thibault, Louapre, Céline, Lubetzki, Catherine, Papeix, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462603/
https://www.ncbi.nlm.nih.gov/pubmed/28616447
http://dx.doi.org/10.1212/NXI.0000000000000346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462603/
https://www.ncbi.nlm.nih.gov/pubmed/28616447
http://dx.doi.org/10.1212/NXI.0000000000000346

Ejemplares similares